It's completely new, yes. Our first publication on the merging of tracking studies with non-lethal physiological samplings came in the science paper that I published back in 2011. That was the very first time this kind of technology had been utilized. Our technology has evolved a lot since then and our genomic technology is much more targeted to specific signatures of stress and disease. It's a lot more powerful than what we had back in 2011 and it's going to be a game-changer in terms of what we understand.
On April 26th, 2021. See this statement in context.